137 related articles for article (PubMed ID: 23472246)
1. The role of hepatic expression of STAT1, SOCS3 and PIAS1 in the response of chronic hepatitis C patients to therapy.
El-Saadany S; Ziada DH; El Bassat H; Farrag W; El-Serogy H; Eid M; Abdallah M; Ghazy M; Salem HA
Can J Gastroenterol; 2013 Feb; 27(2):e13-7. PubMed ID: 23472246
[TBL] [Abstract][Full Text] [Related]
2. Liver expression of proteins controlling interferon-mediated signalling as predictive factors in the response to therapy in patients with hepatitis C virus infection.
Bautista D; Bermúdez-Silva FJ; Lasarte JJ; Rodriguez-Fonseca F; Baixeras E
J Pathol; 2007 Nov; 213(3):347-55. PubMed ID: 17940994
[TBL] [Abstract][Full Text] [Related]
3. Suppressor of cytokine signaling 3 (SOCS3) expression and hepatitis C virus-related chronic hepatitis: Insulin resistance and response to antiviral therapy.
Persico M; Capasso M; Persico E; Svelto M; Russo R; Spano D; Crocè L; La Mura V; Moschella F; Masutti F; Torella R; Tiribelli C; Iolascon A
Hepatology; 2007 Oct; 46(4):1009-15. PubMed ID: 17668875
[TBL] [Abstract][Full Text] [Related]
4. Hepatic SOCS3 expression is strongly associated with non-response to therapy and race in HCV and HCV/HIV infection.
Kim KA; Lin W; Tai AW; Shao RX; Weinberg E; De Sa Borges CB; Bhan AK; Zheng H; Kamegaya Y; Chung RT
J Hepatol; 2009 Apr; 50(4):705-11. PubMed ID: 19231005
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus inhibits interferon signaling through up-regulation of protein phosphatase 2A.
Duong FH; Filipowicz M; Tripodi M; La Monica N; Heim MH
Gastroenterology; 2004 Jan; 126(1):263-77. PubMed ID: 14699505
[TBL] [Abstract][Full Text] [Related]
6. Defective hepatic response to interferon and activation of suppressor of cytokine signaling 3 in chronic hepatitis C.
Huang Y; Feld JJ; Sapp RK; Nanda S; Lin JH; Blatt LM; Fried MW; Murthy K; Liang TJ
Gastroenterology; 2007 Feb; 132(2):733-44. PubMed ID: 17258724
[TBL] [Abstract][Full Text] [Related]
7. Altered expression of interferon-stimulated genes is strongly associated with therapeutic outcomes in hepatitis B virus infection.
Han M; Li Y; Wu W; Zhang Y; Yan W; Luo X; Ning Q
Antiviral Res; 2017 Nov; 147():75-85. PubMed ID: 28988797
[TBL] [Abstract][Full Text] [Related]
8. Interferon-γ-stimulated genes, but not USP18, are expressed in livers of patients with acute hepatitis C.
Dill MT; Makowska Z; Duong FHT; Merkofer F; Filipowicz M; Baumert TF; Tornillo L; Terracciano L; Heim MH
Gastroenterology; 2012 Sep; 143(3):777-786.e6. PubMed ID: 22677194
[TBL] [Abstract][Full Text] [Related]
9. Pegylated IFN-α regulates hepatic gene expression through transient Jak/STAT activation.
Dill MT; Makowska Z; Trincucci G; Gruber AJ; Vogt JE; Filipowicz M; Calabrese D; Krol I; Lau DT; Terracciano L; van Nimwegen E; Roth V; Heim MH
J Clin Invest; 2014 Apr; 124(4):1568-81. PubMed ID: 24569457
[TBL] [Abstract][Full Text] [Related]
10. Characterisation of the cytokine milieu associated with the up-regulation of IL-6 and suppressor of cytokine 3 in chronic hepatitis C treatment non-responders.
Martinez D; Palmer C; Simar D; Cameron BA; Nguyen N; Aggarwal V; Lloyd AR; Zekry A
Liver Int; 2015 Feb; 35(2):463-72. PubMed ID: 24461080
[TBL] [Abstract][Full Text] [Related]
11. Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1.
Walsh MJ; Jonsson JR; Richardson MM; Lipka GM; Purdie DM; Clouston AD; Powell EE
Gut; 2006 Apr; 55(4):529-35. PubMed ID: 16299039
[TBL] [Abstract][Full Text] [Related]
12. Interferon alpha receptors and STAT1 as therapy predictors of a sustained virological response in hepatitis C/B co-infection.
Asim M; Rashid A; Khan A
J Pak Med Assoc; 2018 Nov; 68(11):1446-1450. PubMed ID: 30410131
[TBL] [Abstract][Full Text] [Related]
13. Interferon alpha induced intrahepatic pSTAT1 inversely correlate with serum HCV RNA levels in chronic HCV infection.
Gunduz F; Mallikarjun C; Balart LA; Dash S
Exp Mol Pathol; 2014 Feb; 96(1):36-41. PubMed ID: 24211829
[TBL] [Abstract][Full Text] [Related]
14. Undetectable phospho-STAT1 in peripheral blood mononuclear cells from patients with chronic hepatitis C who do not respond to interferon-alpha therapy.
Aceti A; Zechini B; Griggi T; Marangi M; Pasquazzi C; Quaranta G; Sorice M
Liver Int; 2005 Oct; 25(5):987-93. PubMed ID: 16162158
[TBL] [Abstract][Full Text] [Related]
15. Interferon-gamma inhibits interferon-alpha signalling in hepatic cells: evidence for the involvement of STAT1 induction and hyperexpression of STAT1 in chronic hepatitis C.
Radaeva S; Jaruga B; Kim WH; Heller T; Liang TJ; Gao B
Biochem J; 2004 Apr; 379(Pt 1):199-208. PubMed ID: 14690454
[TBL] [Abstract][Full Text] [Related]
16. Elevated expression and polymorphisms of SOCS3 influence patient response to antiviral therapy in chronic hepatitis C.
Persico M; Capasso M; Russo R; Persico E; Crocè L; Tiribelli C; Iolascon A
Gut; 2008 Apr; 57(4):507-15. PubMed ID: 17881539
[TBL] [Abstract][Full Text] [Related]
17. Malnutrition impairs interferon signaling through mTOR and FoxO pathways in patients with chronic hepatitis C.
Honda M; Takehana K; Sakai A; Tagata Y; Shirasaki T; Nishitani S; Muramatsu T; Yamashita T; Nakamoto Y; Mizukoshi E; Sakai Y; Yamashita T; Nakamura M; Shimakami T; Yi M; Lemon SM; Suzuki T; Wakita T; Kaneko S;
Gastroenterology; 2011 Jul; 141(1):128-40, 140.e1-2. PubMed ID: 21458454
[TBL] [Abstract][Full Text] [Related]
18. Type III Interferon Induces Distinct SOCS1 Expression Pattern that Contributes to Delayed but Prolonged Activation of Jak/STAT Signaling Pathway: Implications for Treatment Non-Response in HCV Patients.
Liu B; Chen S; Guan Y; Chen L
PLoS One; 2015; 10(7):e0133800. PubMed ID: 26193702
[TBL] [Abstract][Full Text] [Related]
19. [Relationship between the suppressor of cytokine signaling 3 expression and antiviral efficacy of nucleos(t)ide and interferon alpha therapy for chronic hepatitis B].
Wang YL; Wu WY; You J; Yan WM; Luo XP; Ning Q; Han MF
Zhonghua Gan Zang Bing Za Zhi; 2019 Jan; 27(1):27-32. PubMed ID: 30685920
[No Abstract] [Full Text] [Related]
20. Suppressor of cytokine signaling 3 suppresses hepatitis C virus replication in an mTOR-dependent manner.
Shao RX; Zhang L; Peng LF; Sun E; Chung WJ; Jang JY; Tsai WL; Hyppolite G; Chung RT
J Virol; 2010 Jun; 84(12):6060-9. PubMed ID: 20375166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
